McDevitt MR - Search Results

1

Evaluation of biological response modifiers in the enhancement of tumor uptake of technetium-99m labeled macromolecules. A preliminary report.

Thakur ML, DeFulvio J, Tong J, John E, McDevitt MR, Damjanov I. Thakur ML, et al. Among authors: mcdevitt mr. J Immunol Methods. 1992 Aug 10;152(2):209-16. doi: 10.1016/0022-1759(92)90142-g. J Immunol Methods. 1992. PMID: 1500731

2

Rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: preparation and evaluation.

John E, Thakur ML, DeFulvio J, McDevitt MR, Damjanov I. John E, et al. Among authors: mcdevitt mr. J Nucl Med. 1993 Feb;34(2):260-7. J Nucl Med. 1993. PMID: 8429345 Free article.

3

Efficient 1-step radiolabeling of monoclonal antibodies to high specific activity with 225Ac for α-particle radioimmunotherapy of cancer.

Maguire WF, McDevitt MR, Smith-Jones PM, Scheinberg DA. Maguire WF, et al. Among authors: mcdevitt mr. J Nucl Med. 2014 Sep;55(9):1492-8. doi: 10.2967/jnumed.114.138347. Epub 2014 Jun 30. J Nucl Med. 2014. PMID: 24982438 Free PMC article.

4

Preparation of alpha-emitting 213Bi-labeled antibody constructs for clinical use.

McDevitt MR, Finn RD, Ma D, Larson SM, Scheinberg DA. McDevitt MR, et al. J Nucl Med. 1999 Oct;40(10):1722-7. J Nucl Med. 1999. PMID: 10520715 Free article.

5

Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry.

Nikula TK, McDevitt MR, Finn RD, Wu C, Kozak RW, Garmestani K, Brechbiel MW, Curcio MJ, Pippin CG, Tiffany-Jones L, Geerlings MW Sr, Apostolidis C, Molinet R, Geerlings MW Jr, Gansow OA, Scheinberg DA. Nikula TK, et al. Among authors: mcdevitt mr. J Nucl Med. 1999 Jan;40(1):166-76. J Nucl Med. 1999. PMID: 9935073 Free article.

6

Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia.

Sgouros G, Ballangrud AM, Jurcic JG, McDevitt MR, Humm JL, Erdi YE, Mehta BM, Finn RD, Larson SM, Scheinberg DA. Sgouros G, et al. Among authors: mcdevitt mr. J Nucl Med. 1999 Nov;40(11):1935-46. J Nucl Med. 1999. PMID: 10565792 Free article. Clinical Trial.

7

Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.

Behling K, Maguire WF, López Puebla JC, Sprinkle SR, Ruggiero A, O'Donoghue J, Gutin PH, Scheinberg DA, McDevitt MR. Behling K, et al. Among authors: mcdevitt mr. J Nucl Med. 2016 Oct;57(10):1576-1582. doi: 10.2967/jnumed.115.171371. Epub 2016 Apr 28. J Nucl Med. 2016. PMID: 27127217 Free PMC article.

8

Radioimmunotherapy with alpha-emitting nuclides.

McDevitt MR, Sgouros G, Finn RD, Humm JL, Jurcic JG, Larson SM, Scheinberg DA. McDevitt MR, et al. Eur J Nucl Med. 1998 Sep;25(9):1341-51. doi: 10.1007/s002590050306. Eur J Nucl Med. 1998. PMID: 9724387 Review.

9

Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates.

Miederer M, McDevitt MR, Sgouros G, Kramer K, Cheung NK, Scheinberg DA. Miederer M, et al. Among authors: mcdevitt mr. J Nucl Med. 2004 Jan;45(1):129-37. J Nucl Med. 2004. PMID: 14734685 Free article.

10

Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes.

McDevitt MR, Chattopadhyay D, Kappel BJ, Jaggi JS, Schiffman SR, Antczak C, Njardarson JT, Brentjens R, Scheinberg DA. McDevitt MR, et al. J Nucl Med. 2007 Jul;48(7):1180-9. doi: 10.2967/jnumed.106.039131. J Nucl Med. 2007. PMID: 17607040 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters